Archives: Agenda

With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run for 30 minutes and be led by a table moderator and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

• Developing evidence generation strategies that align with regulatory expectations and clinical development goals
• Selecting meaningful clinical and patient-centred endpoints to support efficient trial design and execution
• Integrating innovative trial designs, biomarkers, and real-world evidence to strengthen development decisions
• Optimising endpoint strategies to reduce development risk, accelerate approvals, and improve trial outcomes

• Looking at why Europe is losing competitiveness and risks falling behind in trial attractiveness and patient access despite advanced healthcare systems and strong research reputations
• What must change for Europe to remain desirable, including initiatives shaping the future European landscape (FAST‑EU, COMBINE, EU Biotech Act)
• Examining the rise of emerging trial destinations, from China to the Middle East, alongside the ethical responsibilities and more favourable regulatory approvals
• Exploring the role of ISO 18969 in harmonising clinical investigation processes and supporting more efficient trial delivery across Europe

1 seat available for event sponsor

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

• Understanding the evidence and recommendations for meaningful Patient Research Partner (PRP) involvement in clinical research: Review the 2023 EULAR recommendations and explore why involving PRPs from the inception of a research programme can improve the relevance, feasibility and quality of clinical development.
• Recognising the impact of early patient partnership on clinical trial success: Examine how PRP involvement can influence protocol design, patient burden, recruitment, retention, study execution and ultimately support regulatory decision-making and approval readiness.
• Identifying practical approaches to implementation and measurement: Discuss how sponsors, CROs and research teams can operationalise PRP involvement throughout outsourced clinical development programmes, assess current levels of adoption, and measure the value and impact of patient partnership.

• How should clinical trial sponsors allocate resources to accelerate clinical development without compromising quality?
• Making strategic investment decisions across people, technology, quality and partnerships
• Deciding where to build internal capabilities versus leveraging external partners
• Balancing speed, quality and capital efficiency while preparing for the next stage of growth

• Demonstrating how SharePoint can evolve into an intelligent collaboration and knowledge-sharing ecosystem through AI agents and automation
• Showcasing practical applications including automated content classification, intelligent search, chatbots, and workflow automation
• Identifying how AI-enabled knowledge systems can improve information accessibility, collaboration, decision-making, and organisational agility while reducing inefficiencies and knowledge silos across teams